Answer
Nonacog beta pegol (Refixia) had a steady-state geometric mean half-life of 115 hours (CV 10%) at 40 IU/kg in six previously treated adults aged ≥18 years with haemophilia B and factor IX ≤2%.
Sources for this answer
- Refixia 500 IU powder and solvent for solution for injectionNovo Nordisk Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 4Document updated
Sources checked